Opie L H, Lüscher T F, Ferrari R, Hansen J F
Department of Medicine, University of Cape Town, South Africa.
Eur Heart J. 1997 Jan;18 Suppl A:A134-8. doi: 10.1093/eurheartj/18.suppl_a.134.
About one hundred European cardiologists discussed the role of calcium antagonists in the follow-up management of myocardial infarction. beta-blockers are the treatment of choice. Where these are contra-indicated or otherwise unsuitable, many clinicians would use a non-dihydropyridine calcium antagonist alone or in combination with an ACE inhibitor. There is broad agreement that calcium antagonists should not be used in patients with concomitant left ventricular failure. Cholesterol estimation in post-infarction patients is essential.
约一百位欧洲心脏病专家讨论了钙拮抗剂在心肌梗死后续治疗中的作用。β受体阻滞剂是首选治疗药物。在这些药物禁忌或不适用的情况下，许多临床医生会单独使用非二氢吡啶类钙拮抗剂或与血管紧张素转换酶抑制剂联合使用。人们普遍认为，伴有左心室衰竭的患者不应使用钙拮抗剂。对心肌梗死后患者进行胆固醇评估至关重要。
